These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38708109)

  • 1. Retraction: Astragaloside IV (AS-IV) alleviates the malignant biological behavior of hepatocellular carcinoma
    Jiang Z; Mao Z
    RSC Adv; 2024 May; 14(21):14514. PubMed ID: 38708109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astragaloside IV (AS-IV) alleviates the malignant biological behavior of hepatocellular carcinoma
    Jiang Z; Mao Z
    RSC Adv; 2019 Oct; 9(61):35473-35482. PubMed ID: 35528074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway [Retraction].
    Onco Targets Ther; 2023; 16():281-282. PubMed ID: 37113686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction: Upregulation of miR-26b alleviates morphine tolerance by inhibiting BDNF
    Fisher L
    RSC Adv; 2021 Jan; 11(7):4231. PubMed ID: 35427020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragaloside IV suppresses transforming growth factor-β1-induced epithelial-mesenchymal transition through inhibition of Wnt/β-catenin pathway in glioma U251 cells.
    Han J; Shen X; Zhang Y; Wang S; Zhou L
    Biosci Biotechnol Biochem; 2020 Jul; 84(7):1345-1352. PubMed ID: 32154763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside-IV induces the differentiation of bone marrow mesenchymal stem cells into osteoblasts through
    Cao Y; Lv Q; Huang Z; Li Y
    Regen Med; 2023 Jun; 18(6):471-485. PubMed ID: 37254683
    [No Abstract]   [Full Text] [Related]  

  • 7. Matrine improves the hepatic microenvironment and reverses epithelial-mesenchymal transition in hepatocellular carcinoma by inhibiting the Wnt-1/β-catenin signaling pathway.
    Shi J; Zhang H; Han G; Wang J; Han X; Zhao M; Duan X; Mi L; Li N; Yin X; Li C; Yin F
    Am J Transl Res; 2023; 15(8):5047-5070. PubMed ID: 37692966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragalus polysaccharides and astragaloside IV alleviate inflammation in bovine mammary epithelial cells by regulating Wnt/β-catenin signaling pathway.
    Fan J; Jia F; Liu Y; Zhou X
    PLoS One; 2022; 17(7):e0271598. PubMed ID: 35877777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA ASB16-AS1 Promotes Growth and Invasion of Hepatocellular Carcinoma Through Regulating miR-1827/FZD4 Axis and Activating Wnt/β-Catenin Pathway [Retraction].
    Cancer Manag Res; 2022; 14():501-502. PubMed ID: 35177934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
    Lei T; Zhu X; Zhu K; Jia F; Li S
    Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside I Stimulates Osteoblast Differentiation Through the Wnt/β-catenin Signaling Pathway.
    Cheng X; Wei B; Sun L; Hu X; Liang J; Chen Y
    Phytother Res; 2016 Oct; 30(10):1680-1688. PubMed ID: 27397144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma.
    Chen J; Rajasekaran M; Hui KM
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1142-1149. PubMed ID: 28429652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/β-Catenin signaling pathway in hepatocellular carcinoma: pathogenic role and therapeutic target.
    Zhao Z; Cui T; Wei F; Zhou Z; Sun Y; Gao C; Xu X; Zhang H
    Front Oncol; 2024; 14():1367364. PubMed ID: 38634048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV inhibits the up-regulation of Wnt/β-catenin signaling in rats with unilateral ureteral obstruction.
    Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W
    Cell Physiol Biochem; 2014; 33(5):1316-28. PubMed ID: 24802850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retraction: Panax notoginseng saponins regulate VEGF to suppress esophageal squamous cell carcinoma progression
    Fisher L
    RSC Adv; 2021 Feb; 11(11):6258. PubMed ID: 35427054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retraction: FNDC1 promotes the invasiveness of gastric cancer via Wnt/β-catenin signaling pathway and correlates with peritoneal metastasis and prognosis.
    Frontiers Editorial Office
    Front Oncol; 2024; 14():1490592. PubMed ID: 39355126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orcinol Glucoside Facilitates the Shift of MSC Fate to Osteoblast and Prevents Adipogenesis via Wnt/β-Catenin Signaling Pathway [Retraction].
    Drug Des Devel Ther; 2023; 17():959-960. PubMed ID: 37013138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retraction Notice to: Overexpressed lncRNA GATA6-AS1 Inhibits LNM and EMT via FZD4 through the Wnt/β-Catenin Signaling Pathway in GC.
    Li ZT; Zhang X; Wang DW; Xu J; Kou KJ; Wang ZW; Yong G; Liang DS; Sun XY
    Mol Ther Nucleic Acids; 2022 Jun; 28():594. PubMed ID: 35615007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: SPOCK2 Promotes the Malignant Behavior of Ovarian Cancer via Regulation of the Wnt/
    International BR
    Biomed Res Int; 2024; 2024():9861317. PubMed ID: 38230199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
    Jiang N; Chen WJ; Zhang JW; Xu C; Zeng XC; Zhang T; Li Y; Wang GY
    Oncotarget; 2015 Apr; 6(10):7866-79. PubMed ID: 25797263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.